Se ne è già parlato?
www.dermatologytimes.com
Q&A: Pelage's Novel PP405 Advances to Phase 2a for Androgenetic Alopecia
Qing Yu Christina Weng, MD, shares insights into the drug's advancement following preliminary phase 1 findings.
